Deciphera Pharmaceuticals is expected to submit a new drug application in Q2 2024 and submit a marketing authorization application in Q3 2024.
Deciphera Pharmaceuticals预计在2024年第二季度提交新药申请并在2024年第三季度提交营销授权申请。
Deciphera Pharmaceuticals is expected to submit a new drug application in Q2 2024 and submit a marketing authorization application in Q3 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.